Found: 17
Select item for more details and to access through your institution.
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR.
- Published in:
- Cancer Communications, 2023, v. 43, n. 7, p. 808, doi. 10.1002/cac2.12428
- By:
- Publication type:
- Article
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42784-4
- By:
- Publication type:
- Article
Analysis of creep and modulus loss of the wood cell wall.
- Published in:
- Acta Mechanica, 2016, v. 227, n. 11, p. 3191, doi. 10.1007/s00707-015-1532-y
- By:
- Publication type:
- Article
Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01314-w
- By:
- Publication type:
- Article
Chitosan‐Gelatin‐EGCG Nanoparticle‐Meditated LncRNA TMEM44‐AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5‐FU Resistance in Gastric Cancer.
- Published in:
- Advanced Science, 2022, v. 9, n. 22, p. 1, doi. 10.1002/advs.202105077
- By:
- Publication type:
- Article
Chitosan‐Gelatin‐EGCG Nanoparticle‐Meditated LncRNA TMEM44‐AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5‐FU Resistance in Gastric Cancer.
- Published in:
- Advanced Science, 2022, v. 9, p. 1, doi. 10.1002/advs.202105077
- By:
- Publication type:
- Article
Multi-objective optimal design of high-efficient EMI shielding in porous graphene-reinforced nanocomposites.
- Published in:
- International Journal of Mechanics & Materials in Design, 2023, v. 19, n. 3, p. 669, doi. 10.1007/s10999-023-09643-y
- By:
- Publication type:
- Article
Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34753-0
- By:
- Publication type:
- Article
Correction: CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01694-7
- By:
- Publication type:
- Article
CEO Investment Cycles.
- Published in:
- Review of Financial Studies, 2016, v. 29, n. 11, p. 2955, doi. 10.1093/rfs/hhw033
- By:
- Publication type:
- Article
Learning About CEO Ability and Stock Return Volatility.
- Published in:
- Review of Financial Studies, 2015, v. 28, n. 6, p. 1623, doi. 10.1093/rfs/hhv014
- By:
- Publication type:
- Article
Corporate Risk Culture.
- Published in:
- Journal of Financial & Quantitative Analysis, 2017, v. 52, n. 6, p. 2327, doi. 10.1017/S0022109017000771
- By:
- Publication type:
- Article
The Determinants and Impact of Executive-Firm Matches.
- Published in:
- Management Science, 2017, v. 63, n. 1, p. 185, doi. 10.1287/mnsc.2015.2278
- By:
- Publication type:
- Article
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1.
- Published in:
- Advanced Science, 2023, v. 10, n. 11, p. 1, doi. 10.1002/advs.202206792
- By:
- Publication type:
- Article
The Cultural Origin of CEOs' Attitudes toward Uncertainty: Evidence from Corporate Acquisitions.
- Published in:
- Review of Financial Studies, 2020, v. 33, n. 7, p. 2977, doi. 10.1093/rfs/hhz109
- By:
- Publication type:
- Article
How Management Risk Affects Corporate Debt.
- Published in:
- Review of Financial Studies, 2018, v. 31, n. 9, p. 3491, doi. 10.1093/rfs/hhx071
- By:
- Publication type:
- Article